Naunyn-Schmiedeberg's archives of pharmacology
Repurposing of semaglutide by targeting SIRT1 and TGF-β/Smad signaling in hepatic fibrosis.
Omnia A Hawary, Walaa Wadie, Yasmin A M El-Said, Omnia F Hassan
Published: 202510.1007/s00210-025-04675-x
Abstract
The transforming growth factor-β (TGF-β)/Suppressor of Mothers against Decapentaplegic (Smad) signaling pathway plays an important role in the pathogenesis and progression of liver fibrosis. This current study was conducted to investigate the effect…
Preview only. Read the full abstract at the source